Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Announces Earnings Results

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) posted its quarterly earnings results on Wednesday. The company reported $0.18 EPS for the quarter, Zacks reports.

Fresenius SE & Co. KGaA Stock Down 0.8 %

Fresenius SE & Co. KGaA stock traded down $0.07 during trading on Wednesday, reaching $9.69. 70,325 shares of the company were exchanged, compared to its average volume of 62,937. The stock’s 50 day simple moving average is $9.31 and its two-hundred day simple moving average is $9.18. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36. Fresenius SE & Co. KGaA has a 52-week low of $6.57 and a 52-week high of $10.15.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Fresenius SE & Co. KGaA in a report on Monday, February 3rd.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.